1. Home
  2. Analysis
  3. Victoza
  4. Tremfya

Victoza and Tremfya drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Victoza (liraglutide) and Tremfya (guselkumab). Common drug interactions include decreased appetite among females and myalgia among males.

The phase IV clinical study analyzes what interactions people have when they take Victoza and Tremfya. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Victoza?

Victoza has active ingredients of liraglutide. It is often used in diabetes. eHealthMe is studying from 42,880 Victoza users. Check the latest studies of Victoza.

What is Tremfya?

Tremfya has active ingredients of guselkumab. eHealthMe is studying from 22,557 Tremfya users. Check the latest studies of Tremfya.

On Jul, 18, 2026

12 people who take Victoza and Tremfya together, and have interactions are studied.

Victoza and Tremfya drug interactions.

What are the common drug interactions of Victoza and Tremfya, by gender? *:

female:

  1. Decreased appetite
  2. Injection site nodule (small swelling or aggregation of cells in the body, esp. an abnormal one at injection site)
  3. Injection site pain
  4. Nervousness
  5. Productive cough
  6. Skin atrophy (wasting of skin)
  7. Drug ineffective
  8. Psoriasis (immune-mediated disease that affects the skin)
  9. Diarrhoea
  10. Nausea (feeling of having an urge to vomit)

male:

  1. Myalgia (muscle pain)
  2. Cardiac arrest

What are the common drug interactions of Victoza and Tremfya, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Diarrhoea
  2. Nausea (feeling of having an urge to vomit)
  3. Vomiting
  4. Abdominal discomfort
  5. Nervousness
  6. Productive cough
  7. Cough
  8. Upper respiratory tract infection

50-59:

n/a

60+:

  1. Myalgia (muscle pain)
  2. Psoriasis (immune-mediated disease that affects the skin)

What are the existing conditions these people have? *

  1. Psoriasis (immune-mediated disease that affects the skin): 9 people, 75.00%
  2. Depression: 4 people, 33.33%
  3. Type 2 Diabetes: 3 people, 25.00%
  4. Pain: 3 people, 25.00%
  5. Hypokalemia (low potassium): 3 people, 25.00%
  6. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 16.67%
  7. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 16.67%
  8. Pustular Psoriasis (raised bumps on the skin that are filled with pus): 1 person, 8.33%
  9. Hypogonadism (reduction or absence of hormone secretion or other physiological activity of the gonads (testes or ovaries)): 1 person, 8.33%
  10. Dyslipidaemia (abnormal amount of lipids): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Victoza and Tremfya?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Victoza and Tremfya:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Victoza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tremfya:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Victoza and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tremfya and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on liraglutide and guselkumab (the active ingredients of Victoza and Tremfya, respectively), and Victoza and Tremfya (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.